Login      Sign-Up  
Skip Navigation Links
Home
Laws
Bills
Sessions
House
Senate
Committees
Legislators
My Legis
2026 Regular Session
Other Sessions
Scroll up
Scroll down
2026 Regular Session
Other Sessions
Scroll up
Scroll down
House Committees
Senate Committees
Miscellaneous Committees
Scheduled Meetings
Scroll up
Scroll down
Representatives
Senators
Caucuses and Delegations
Scroll up
Scroll down
      RS 40:2255.1     

  

PART VIII. PHARMACEUTICAL COST TRANSPARENCY

SUBPART A. GENERAL PROVISIONS

§2255.1. Definitions

            As used in this Part, the following words have the following meanings unless the context indicates otherwise:

            (1) "Prescription drug" means a drug as defined in 21 U.S.C. 321.

            (2) "Prescription drug marketing" means to provide educational or marketing information or materials regarding a prescription drug in any form including but not limited to all of the following:

            (a) Face-to-face meetings.

            (b) Physical mailings.

            (c) Telephone conversations.

            (d) Electronic mail or facsimile.

            Acts 2017, No. 220, §1.



If you experience any technical difficulties navigating this website, contact the webmaster.
P.O. Box 94062 (900 North Third Street) Baton Rouge, Louisiana 70804-9062